文献速递肺血管病与心包/心肌炎

慢性肢体威胁性缺血治疗与结局的性别差异:真实世界队列研究

Sex-related differences in treatment and outcome of chronic limb-threatening ischaemia: a real-world cohort.
PubMed 文献 · Eur Heart J · 2022-01-01

女性患者年龄更大、合并高血压、房颤、心衰和慢性肾病更多,接受诊断性血管造影、血运重建及指南推荐药物(他汀、抗血栓)的比例均低于男性。校正年龄和合并症后,女性性别与更好的总生存和无截肢生存独立相关。

要点

  • 女性CLTI患者年龄更大且高血压、房颤、心衰、慢性肾病负担更重。
  • 女性接受血管造影、血运重建及他汀/抗血栓治疗的比例均低于男性。
  • 校正年龄和合并症后,女性性别与更好的总生存和无截肢生存独立相关。

核心结论

  • 女性CLTI患者年龄更大、接受血管操作和指南推荐药物更少,但女性性别独立关联更好的总生存和无截肢生存。

研究设计与样本

  • 基线期为索引住院前2年以评估合并症和既往操作,随访期至2018年。

主要发现

  • 女性患者中位年龄81.4岁,男性73.8岁(P < 0.001)。
  • 女性更常诊断高血压、房颤、慢性心衰和慢性肾病,男性更常诊断糖尿病、血脂异常、吸烟、脑血管病和慢性冠脉综合征(均P < 0.001)。
  • 住院CLTI患者中女性占43%,男性占57%(P < 0.001)。
  • 住院期间女性接受诊断性血管造影67% vs 男性70%,血运重建61% vs 65%(均P < 0.001)。
  • 基线时女性接受他汀35% vs 男性43%,抗血栓治疗48% vs 53%(均P < 0.001)。

临床怎么用

  • 临床中应关注女性CLTI患者接受血管造影、血运重建及指南推荐药物(他汀、抗血栓)比例偏低的现象。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS: The prevalence of chronic limb-threatening ischaemia (CLTI) is increasing and available data often derive from cohorts with various selection criteria. In the present study, we included CLTI patients and studied sex-related differences in their risk profile, vascular procedures, and long-term outcome. METHODS AND RESULTS: We analysed 199 953 unselected patients of the largest public health insurance in Germany (AOK: Local healthcare funds), hospitalized between 2010 and 2017 for a main diagnosis of CLTI. A baseline period of 2 years before index hospitalization to assess comorbidities and previous procedures, and a follow-up period until 2018 were included. Female CLTI patients were older (median 81.4 vs. 73.8 years in males; P < 0.001) and more often diagnosed with hypertension, atrial fibrillation, chronic heart failure, and chronic kidney disease. Male patients suffered more frequently from diabetes mellitus, dyslipidaemia, smoking, cerebrovascular disease, and chronic coronary syndrome (all P < 0.001). Within hospitalized CLTI patients, females represent the minority (43% vs. 57%; P < 0.001) and during index hospitalization, women underwent less frequently diagnostic angiographies (67 vs. 70%) and revascularization procedures (61 vs. 65%; both P < 0.001). Moreover, women received less frequently guideline-recommended drugs like statins (35 vs. 43%) and antithrombotic therapy (48 vs. 53%; both P < 0.001) at baseline. Interestingly, after including age and comorbidities in a Cox regression analysis, female sex was associated with increased overall-survival (OS) [hazard ratio (HR) 0.95; 95% confidence interval (CI) 0.94-0.96] and amputation-free survival (AFS) (HR 0.84; 95% CI 0.83-0.85; both P < 0.001). CONCLUSION: Female patients with CLTI were older, underwent less often vascular procedures, and received less frequently guideline-recommended medication. Nevertheless, female sex was independently associated with better OS and AFS during follow-up.

来源:Eur Heart J,查看原文。版权归原作者所有。

引用

  1. Makowski L, Köppe J, Engelbertz C, et al. Sex-related differences in treatment and outcome of chronic limb-threatening ischaemia: a real-world cohort. Eur Heart J. 2022. PMID: 35134893. doi:10.1093/eurheartj/ehac016

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。